ENTX NASDAQ
Entera Bio Ltd.
1W: +4.0%
1M: -2.0%
3M: +67.2%
YTD: +61.6%
1Y: +54.6%
3Y: +297.8%
5Y: -40.5%
$2.86
-0.03 (-1.04%)
Weekly Expected Move ±6.8%
$2
$3
$3
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$42K
-76.8% ▼
5Y CAGR: -35.1%
Gross Profit
-$30K
-433.3% ▼
Operating Income
-$12M
-20.3% ▼
Net Income
-$11M
-19.9% ▼
EPS (Diluted)
$-0.25
+0.0% ▲
EBITDA
-$11M
-20.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $571K | $134K | $0 | $181K | $42K |
| YoY Growth | +56.4% | -76.5% | -100.0% | +0.0% | -76.8% |
| Cost of Revenue | $373K | $165K | $56K | $172K | $72K |
| Gross Profit | $198K | -$31K | -$56K | $9K | -$30K |
| Gross Margin | 34.7% | -23.1% | — | 5.0% | -71.4% |
| R&D Expenses | $7M | $6M | $4M | $4M | $6M |
| SG&A Expenses | $6M | $7M | $4M | $5M | $6M |
| Operating Expenses | $12M | $13M | $9M | $10M | $12M |
| Operating Income | -$12M | -$13M | -$9M | -$10M | -$12M |
| Operating Margin | -2139.6% | -9752.2% | — | -5295.6% | -27450.0% |
| Interest Expense | $29K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$12M | -$13M | -$9M | -$10M | -$11M |
| Tax Expense | -$59K | $137K | $29K | $14K | $12M |
| Net Income | -$12M | -$13M | -$9M | -$10M | -$11M |
| Net Margin | -2134.3% | -9754.5% | — | -5271.3% | -27235.7% |
| EPS (Diluted) | $-0.47 | $-0.45 | $-0.31 | $-0.25 | $-0.25 |
| EBITDA | -$12M | -$13M | -$9M | -$10M | -$11M |
| Shares Outstanding | 26M | 29M | 29M | 38M | 46M |